Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Malignant melanoma metastatic

Propper DJ, Macaulay V, O Byrne KJ, Braybrooke JP, Wilner SM, Ganesan TS, Talbot DC, Harris AL (1998) A phase II study of bryostatin 1 in metastatic malignant melanoma. Br J Cancer 78 1337-1341... [Pg.87]

Robinson, W.A., T.I. Mughal, M.R. Thomas, M. Johnson, and R.J. Spiegel, Treatment of metastatic malignant melanoma with recombinant interferon alpha 2. Immunobiology, 1986. 172(3-5) 275-82. [Pg.177]

Falkson, C.I., J. Ibrahim, J.M. Kirkwood, A.S. Coates, M.B. Atkins, and R.H. Blnm, Phase HI trial of dacarbazine versus dacarbazine with interferon alpha-2b versus dacarbazine with tamoxifen versus dacarbazine with interferon alpha-2b and tamoxifen in patients with metastatic malignant melanoma an Eastern Cooperative Oncology Group study. J Clin Oncol, 1998.16(5) 1743-51. [Pg.177]

H. Other considerations Interferon alfa-2a has been designated an orphan drug product for the treatment of chronic myelogenous leukemia, AIDS-related Kaposi s sarcoma, renal cell carcinoma, metastatic malignant melanoma, and esophageal and colorectal cancer. [Pg.192]

Permanent hypothyroidism associated with vitiligo was reported in a woman treated with interleukin-4 for metastatic malignant melanoma (SEDA-20, 336). [Pg.612]

Kunz M, Koczan D, Ibrahim S, Gillitzer R, Gross G, Thiesen H. Differential expression of thrombospondin 2 in primary and metastatic malignant melanoma. Acta Derm Venereol 2002 82 163-169. [Pg.215]

Bar MH, Snzol M, Atkins MB, et al. Metastatic malignant melanoma treated with combined bolus and continuous infusion interleukin-2 and lymphokine activated killer cells. J Clin Oncol 1990 8 1138-47. [Pg.778]

Letellier S, Gamier JP, Spy J, Bousquet B. Determination of the L-DOPA/L-tyrosine ratio in human plasma by high-performance liquid chromatography. Usefulness as a marker in metastatic malignant melanoma. J Chromatogr B Biomed Sci Appl 1997 696 9-17. [Pg.1071]

Figure 4.2 Variation of retention time of l-DOPA as a function of pH of the mobile phase. As the pH increases, the retention time of l-DOPA decreases. NE, norepinephrine E, epinephrine DA, dopamine DHBA, internal standard. Reprinted from Journal of Chromatography B, 696, Letellier S, Gamier JP, Spy J, Bousquet B. Determination of the L-DOPA/L-tyrosine ratio in human plasma by high-performance liquid chromatography. Usefulness as a marker in metastatic malignant melanoma, pages 9-17, Copyright 1997, with permission from Elsevier... Figure 4.2 Variation of retention time of l-DOPA as a function of pH of the mobile phase. As the pH increases, the retention time of l-DOPA decreases. NE, norepinephrine E, epinephrine DA, dopamine DHBA, internal standard. Reprinted from Journal of Chromatography B, 696, Letellier S, Gamier JP, Spy J, Bousquet B. Determination of the L-DOPA/L-tyrosine ratio in human plasma by high-performance liquid chromatography. Usefulness as a marker in metastatic malignant melanoma, pages 9-17, Copyright 1997, with permission from Elsevier...
O Day SJ, Agarwala SS, Naredi P, Kass CL, et al. Treatment with histamine dihydrochloride and interleukin-2 in patients with advanced metastatic malignant melanoma a detailed safety analysis. Melanoma Res 2003 13 307-311. [Pg.2539]

FIGURE 4.22 Epithelioid angiosarcoma is potentially confused diagnostically with metastatic malignant melanoma or poorly differentiated carcinoma in the soft tissues. [Pg.113]

Fetsch PA, Marincola FM, Filie A, et al. Melanoma-associated antigen recognized by T-cells (MART-1) The advent of a preferred immunocytochemical antibody for the diagnosis of metastatic malignant melanoma with fine needle aspiration. Cancer. 1999 87 37-42. [Pg.129]

King R, Busam K, Rosai J. Metastatic malignant melanoma resembling malignant peripheral nerve sheath tumor Report of 16 cases. Am J Surg Pathol. 1999 23 1499-1505. [Pg.133]

Selby WL, Nance KV, Park KH. Carcinoembryonic antigen— immunoreactivity in metastatic malignant melanoma. Mod Pathol. 1992 5 415-419. [Pg.200]

Plaza JA, Sustet S, Petez-Montiel D. Exptession of immunohistochemical matkets in ptimaty and metastatic malignant melanoma a compatative study in 70 patients using a tissue microattay technique. Appl Immunohistochem Mol Morphol. 2007 15 421-425. [Pg.204]

S-100 may be part of a panel when considering a metastatic malignant melanoma however, sustentacular cells in the adrenal medulla are also positive for this marker. Additionally, HMB-45, which is known to be positive in malignant melanomas, is occasionally positive in pheochromocytomas. 9262... [Pg.316]

FIGURE 21.14 Metastatic malignant melanoma. (A) FNA cytology of an axillary mass. (B) Pleural effusion. [Pg.908]

Advanced colorectal cancer and esophageal carcinoma Metastatic malignant melanoma and renal-cell carcinoma... [Pg.522]

Protein of rDNA origin that is used in treating renal cell carcinoma and metastatic malignant melanoma. [Pg.322]

Bedikian AY, Deconti RC, Conry R, Agarwala S, Papadopoulos N, Kim KB, Ernstoff M. Phase 3 study of docosahexaenoic acid-paclitaxel versus dacarbazine in patients with metastatic malignant melanoma. Ann Oncol 2011 22(4) 787-93. [Pg.957]

See other pages where Malignant melanoma metastatic is mentioned: [Pg.41]    [Pg.239]    [Pg.29]    [Pg.160]    [Pg.41]    [Pg.29]    [Pg.153]    [Pg.120]    [Pg.732]    [Pg.1208]    [Pg.798]    [Pg.90]    [Pg.88]    [Pg.181]    [Pg.120]    [Pg.546]    [Pg.577]    [Pg.880]    [Pg.1714]    [Pg.475]   
See also in sourсe #XX -- [ Pg.153 ]



SEARCH



Malignancy

Malignant

Malignant melanoma

Metastatic malignancies

Metastatic melanoma

© 2024 chempedia.info